The technology is able to take a single-lead ECG in 30 seconds.
AliveCor is rolling out a new credit-card-size personal ECG called the KardiaMobile Card. The technology, which landed FDA clearance in November, is able to take a single-lead ECG in 30 seconds.
The Bluetooth-backed technology is able to pair with a smartphone and detect six types of arrhythmias including; AFIB, Bradycardia, Tachycardia, PVCs, Sinus Rhythm with SVE and Sinus Rhythm with Wide QRS.
The $149 card comes with a year of KardiaCare, which gives users access to heart health reports, cardiologist ECG reviews, cloud storage, automatic ECG sharing, weight and blood pressure monitoring, and medication-tracking.
According to the CDC, heart disease is the number one cause of death in the U.S. for “men, women and people from most racial and ethnic groups.” Heart disease accounts for one in every four deaths.
Healthy habits, such as eating healthful foods, keeping a healthy weight and regular physical activity, can help prevent heart disease.
AliveCor is pitching the technology as a way to help individuals monitor their heart condition outside of a clinical care setting.
“KardiaMobile Card delivers the most sophisticated AI in the most convenient form factor ever, putting the power of real-time ECG analysis directly in patients’ wallets and furthering our vision of becoming the 24/7 virtual cardiologist for patients when they’re not in front of their physician,” Priya Abani, CEO of AliveCor, said in a statement.
AliveCor has been in the cardiac monitoring space since 2011. In 2019, the company landed FDA 510(k) clearance for its six-lead ECG device called KardiaMobile 6L, as well as KardiaAI. In 2020, the company added the digital subscription service KardiaCare to its offerings.
The company has also teamed up with pharma in the past. In 2021, AliveCor announced a partnership with AstraZeneca to study new ways of managing cardiac, renal and metabolic issues.
In April, AliveCor filed a complaint with the U.S. International Trade Commission alleging that Apple breached patent laws on three of AliveCor’s technologies. The company had a history of working with Apple. In 2017, it announced that its KardiaBand could be used as an add-on accessory to Apple Watch bands. However, sales ended shortly after Apple’s ECG capabilities went live.
Like Apple, there are many consumer wearables that have added the ECG feature. For example, Withings, Fitbit and Samsung have added ECG-monitoring to their wearables.
